Jian He

Jian He

Auto-generated profile, based on publicly available information

Jian He

Department of Magnetic Resonance Imaging (D.Z., L.Z., S.L., B.Z., J.X., W.Y., J.H., Y.W., S.Z., M.L.), Fuwai Hospital and National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2021 in Radiology
Verified
Journal Article
Closed access
JHJian He
Jian He
WYWenjing Yang
Wenjing Yang
WWWeichun Wu
Weichun Wu
SLShuang Li
Shuang Li
GYGang Yin
Gang Yin
MLMinjie Lu
Minjie Lu
Left ventricular global early diastolic longitudinal strain rate, an easily quantifiable marker derived from cardiovascular MRI feature tracking, was independently associated with adverse outcomes ... Background Assessment of subclinical myocardial dysfunction by using feature tracking has shown promise in prognosis evaluation of heart failure with preserved ejection fraction (HFpEF). Global ear...

7 September 2020 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
PDF file
JHJian He
Jian He
ASArlene Sirajuddin
Arlene Sirajuddin
SLShuang Li
Shuang Li
BZBaiyan Zhuang
Baiyan Zhuang
JXJing Xu
Jing Xu
MLMinjie Lu
Minjie Lu

3 November 2022 in eClinicalMedicine
Verified
Journal Article
Open access
JHJian He
Jian He
WYWenjing Yang
Wenjing Yang
WWWeichun Wu
Weichun Wu
XSXiaoxin Sun
Xiaoxin Sun
SLShuang Li
Shuang Li
MLMinjie Lu
Minjie Lu
The pathophysiology and subsequent myocardial dysfunction of heart failure with preserved ejection fraction (HFpEF) with comorbid obesity has not been extensively described. This study aimed to investigate the clinical features and cardiovascular magnetic resonance (CMR) derived myocardial strain and tissue characteristics in patients with HFpEF and comorbid obesity phenotype. In this prospective cohort study, we included consecutive patients admitted to Fuwai hospital in China who underwent CMR. Patients with HFpEF or obesity were diagnosed with demographic data, clinical presentation, laboratory test, and echocardiography or CMR imaging. The key exclusion criteria were cardiomyopathy, primary valvular heart disease, and significant coronary artery disease. Participant data were obtained from the electronic medical records database or inquiry. Comparisons of clinical features and CMR derived structural and functional parameters amongst different groups were made using one-way analysis of variance, or χ2 tests, and post hoc Bonferroni analysis where appropriate. Between January 1, 2019 and July 31, 2021, 280 participants (108 patients with HFpEF and obesity, 50 patients with HFpEF and normal weight, 72 patients with obesity, and 50 healthy controls) were enrolled. Compared with patients with HFpEF and normal weight, patients with HFpEF and obesity were younger males, and had higher plasma volume, uric acid and hemoglobin levels, yet less often atrial fibrillation, and lower NT-proBNP levels, and had higher left ventricular mass index, end-diastole/systole volume index, lower left atrial volume index, and worse myocardial strains (all p ≤ 0.05), but no remarkable difference in late gadolinium enhancement (LGE) presence and extracellular volume fraction (ECV). After adjusting for age, atrial fibrillation, and coronary artery disease, only global longitudinal strain (GLS, p = 0.031) and early-diastolic global longitudinal strain rate (eGLSR, p = 0.043) were considerably worse in patients with HFpEF and obesity versus patients with HFpEF and normal weight. Furthermore, early-diastolic strain rates showed no linear association with ECV in patients with HFpEF and obesity. Moreover, GLS demonstrated the highest diagnostic ability when compared with traditional CMR structural parameters and ECV to diagnose patients with HFpEF and obesity in the setting of obesity. Higher systemic inflammation, and worse GLS and eGLSR may be the distinct features of obesity-related HFpEF phenotype; strains and ECV may represent different mechanisms of HFpEF with obesity, deserving further study. The Construction Research Project of Key Laboratory (Cultivation) of Chinese Academy of Medical Sciences (2019PT310025); 10.13039/501100001809 National Natural Science Foundation of China (81971588); Capital’s Funds for Health Improvement and Research (CFH 2020-2-4034); Youth Key Program of High-level Hospital Clinical Research (2022-GSP-QZ-5).

1 November 1996 in Heart
Verified
Journal Article
Open access
PDF file
LJL. Jiang
L. Jiang
NWN. J. Weissman
N. J. Weissman
JMJosé Luis Guerrero Márquez
José Luis Guerrero Márquez
JHJ. He
J. He
AWA. E. Weyman
A. E. Weyman
MPM. H. Picard
M. H. Picard
OBJECTIVE: To evaluate the feasibility and ability of percutaneous transvenous intracardiac echocardiography (ICE) to image the left ventricle (LV) and monitor its function from the right ventricular (RV) cavity. METHODS: A 10 MHz catheter was advanced into the RV from the jugular vein and positioned along the septum at the LV papillary muscle level in five dogs. The catheter was manipulated until a stable catheter position along the septum, which provided on-axis images of LV, was obtained. Different states of LV size and systolic function (n = 80) were created with dobutamine or esmolol, both in the presence and absence of coronary stenoses. LV stroke area (cm2) obtained by ICE was measured at the mid-ventricular level and compared with stroke volume (cm3) obtained simultaneously with a transaortic flow probe. LV end diastolic, end systolic, and stroke areas obtained by ICE were also compared with those obtained by short-axis epicardial echocardiography. RESULTS: In 96% of the stages, short axis images of the LV could be obtained and measured by ICE. LV end diastolic, end systolic, and stroke areas measured by ICE were not significantly different from epicardial echocardiographic values. Stroke area correlated with stroke volume in each dog (mean correlation coefficient 0.79 (SEE 0.19) cm2) (P < 0.001). CONCLUSIONS: Percutaneous intracardiac ultrasound imaging allows monitoring of LV function from the RV with an accuracy comparable to a short-axis epicardial echocardiogram. The present device can be used in closed chest experimental studies. With the development of lower frequency devices, this technique may be valuable for continuous monitoring of LV function in patients in the intensive care unit or operating room.

1 March 2025 in Circulation: Cardiovascular Imaging
Verified
Journal Article
Open access
DZDi Zhou
Di Zhou
LZLeyi Zhu
Leyi Zhu
SLShuang Li
Shuang Li
WWWeichun Wu
Weichun Wu
BZBaiyan Zhuang
Baiyan Zhuang
MLMinjie Lu
Minjie Lu
BACKGROUND: Current guidelines recommend implantable cardioverter defibrillators for the primary prevention of sudden cardiac death (SCD) in patients with dilated cardiomyopathy with left ventricular ejection fraction (LVEF)≤35%. However, its effectiveness is hindered by the inability to reliably discriminate between the risk of SCD and competing death of heart failure deterioration, thereby limiting its clinical utility. We aimed to refine the SCD risk stratification model based on cardiac magnetic resonance imaging for patients with dilated cardiomyopathy with LVEF≤35%. METHODS: A total of 1272 patients with dilated cardiomyopathy with LVEF≤35% who underwent cardiac magnetic resonance imaging were consecutively enrolled in this study. The primary end point is a composite of SCD or aborted SCD and the second end point is a composite of heart failure death and heart transplantation. RESULTS: Over a median follow-up of 86.3 months, 101 patients reached the primary end point. In the adjusted analysis, age (hazard ratio [HR], 1.02 [95% CI, 1.01–1.04]; P =0.006) years, a family history of SCD (HR, 2.00 [95% CI, 1.01–3.98]; P =0.05), NT-proBNP (N-terminal pro-B-type natriuretic peptide) (HR, 2.02 [95% CI, 1.18–3.44]; P =0.01), LVEF (per 5% HR, 0.79 [95% CI, 0.66–0.95]; P =0.01), and late gadolinium enhancement≥7.5% (HR, 4.11[95% CI, 2.72–6.21]; P <0.001) were associated with SCD or aborted SCD. Left atrial volume index≥68.3 mL/m 2 was an independent predictor of the secondary end point (adjusted HR, 1.65 [95% CI, 1.13–2.40]; P =0.009). Compared with late gadolinium enhancement<7.5%, patients with late gadolinium enhancement≥7.5% and LVEF≤20% had a 7.12-fold higher risk of experiencing SCD events in competing Cox analysis (annual event rate, 4.8%). CONCLUSIONS: Patients with dilated cardiomyopathy with late gadolinium enhancement≥7.5% were at heightened risk of SCD events, which can be used for risk assessment. Risk stratifications for SCD, combining clinical and cardiac magnetic resonance imaging may potentially guide decision-making for implantable cardioverter defibrillator therapy.

10 January 2022 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
PDF file
WYWenjing Yang
Wenjing Yang
HLHongwen Li
Hongwen Li
JHJian He
Jian He
GYGang Yin
Gang Yin
JAJing An
Jing An
MLMinjie Lu
Minjie Lu